Press release
Cancer Diagnostics Market Insights, Outlook and Forecast 2024 - 2028
Cancer Diagnostics Market
Market Overview
Cancer diagnostics encompass a wide range of tests and procedures used to detect, diagnose, and monitor cancer. These include imaging techniques like X-rays and MRIs, biopsies, and blood tests. The growing adoption of minimally invasive and personalized medicine approaches is also shaping the market landscape.
Claim Your FREE Sample Copy with Table of content@ https://www.reportsanddata.com/download-free-sample/3707
Key Trends
Rising Cancer Burden: The increasing incidence of cancer globally is a major driver for the market. The National Cancer Institute estimates that new cancer cases are expected to rise to 29.5 million per year.
Technological Advancements: Advancements in technologies like liquid biopsies, next-generation sequencing (NGS), and companion diagnostics are improving accuracy, efficiency, and personalization in cancer diagnosis.
Focus on Early Detection: Growing public awareness about early detection of cancer is propelling the demand for advanced screening tests.
Drivers and Restraints
Increasing Government Initiatives: Government initiatives aimed at promoting cancer awareness and early detection programs are driving market growth.
Growing Healthcare Expenditure: Rising healthcare spending, particularly in developed countries, is creating a favorable environment for market expansion.
Stringent Regulations: Stringent regulatory processes for approval of new diagnostic tests can hinder market growth.
Reimbursement Challenges: Reimbursement limitations for some diagnostic procedures can pose a challenge for widespread adoption.
For more informative information, please visit us @ https://www.reportsanddata.com/report-detail/cancer-diagnostics-market
Growth Opportunities
Emerging Markets: The growing healthcare infrastructure and increasing disposable income in developing economies present lucrative opportunities.
Personalized Medicine: Advancements in personalized medicine hold immense potential for tailored cancer diagnostic approaches.
Artificial Intelligence (AI): Integration of AI in diagnostics can enhance accuracy, efficiency, and early detection capabilities.
Key Market Insights
The market is segmented by technology, application, end-user, and geography.
Imaging techniques currently dominate the market, but molecular diagnostics are expected to witness significant growth.
Hospitals are the primary end-users, but diagnostic laboratories are gaining traction.
North America is the largest regional market, followed by Europe and Asia Pacific.
SWOT Analysis
Strengths
Technological advancements
Growing demand for early detection
Rising healthcare expenditure
Weaknesses
Stringent regulations
Reimbursement challenges
Limited access in some regions
Opportunities
Emerging markets
Personalized medicine
AI integration
Threats
Patent expiries
Competition from generic diagnostics
Latest Developments
In February 2020, Cepheid made an announcement about entering into a collaborative agreement with Sherlock Biosciences for the exploration of the innovative ground-breaking molecular diagnostic tests development intended for oncology and infectious diseases deploying CRISPR technology.
Companies considered and profiled in this market study
Thermo Fisher Scientific, Hologic Inc., Abbott Laboratories, Siemens Healthineers, GE Healthcare, Illumina Inc., F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, Qiagen, and Becton, Dickinson, and Company, has been profiled in the report.
Segments Covered in the report
This report forecasts revenue growth at a global, regional & country level and provides an analysis of the market trends in each of the sub-segments from 2018 to 2028. The scope of the report can be defined as:
For the purpose of this report, Reports and Data has segmented into the global cancer diagnostics on the basis of test type, application, end-user, and region:
Test Type Outlook (Revenue, USD Billion; 2018-2028)
Imaging
Laboratory Test
Genetic Test
Biopsy
Endoscopy
Others
Application Outlook (Revenue, USD Billion; 2018-2028)
Breast Cancer
Colorectal Cancer
Cervical Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Blood Cancer
Ovarian Cancer
Others
End-User Outlook (Revenue, USD Billion; 2018-2028)
Hospitals & Clinics
Diagnostic Centers
Research Institutes
Others
Ask For Customization: https://www.reportsanddata.com/request-customization-form/3707
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Diagnostics Market Insights, Outlook and Forecast 2024 - 2028 here
News-ID: 3558199 • Views: …
More Releases from Reports and Data
U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billio …
The U.S. Electric Vehicle (EV) Charging Infrastructure Market reached a value of USD 5.48 billion in 2024 and is projected to surge to USD 56.73 billion by 2034, fueled by a robust CAGR of 26.1% over the period. This unprecedented growth underscores the sector's central role in decarbonizing transportation and meeting the soaring demands of electric mobility.
Market Drivers
Federal & State Policies: Major initiatives, including the Bipartisan Infrastructure Law and significant…
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Dr …
The global Automotive Refurbished Turbochargers Market is set to grow from USD 0.9 billion in 2024 to USD 1.7 billion by 2034, recording a steady compound annual growth rate (CAGR) of 6.00%. This growth is being propelled by rising demand for affordable, fuel-efficient automotive solutions and stricter environmental regulations pushing the need for emission-reducing technologies.
Get Free Sample Report and Related Graphs & Charts @https://www.reportsanddata.com/sample-enquiry-form/19490
Passenger vehicles remain the largest segment of…
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Dr …
The global Automotive Powertrain Cooling System Market is projected to grow from USD 4.3 billion in 2024 to USD 8.2 billion by 2034, at a CAGR of 6.60%, according to the latest market study. This growth is fueled by the rising demand for fuel-efficient vehicles, increasing electric vehicle (EV) sales, and stricter global emission regulations.
Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.reportsanddata.com/sample-enquiry-form/19489
Electric and…
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
The global Automotive Inverter Market is on track for strong expansion, with forecasts projecting it will rise from USD 4.8 billion in 2024 to USD 16.9 billion by 2034, marking a compound annual growth rate (CAGR) of 13.2%. This rapid growth is being propelled by the increasing adoption of electric and hybrid vehicles, along with continued innovation in inverter technologies.
Electric vehicles (EVs) are the main driver behind this surge, as…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
